Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2007319rdf:typepubmed:Citationlld:pubmed
pubmed-article:2007319lifeskim:mentionsumls-concept:C0006644lld:lifeskim
pubmed-article:2007319lifeskim:mentionsumls-concept:C0039771lld:lifeskim
pubmed-article:2007319lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:2007319pubmed:issue3lld:pubmed
pubmed-article:2007319pubmed:dateCreated1991-4-29lld:pubmed
pubmed-article:2007319pubmed:abstractTextDuring this open, two-period crossover study in eight healthy volunteers, 1200 mg anhydrous theophylline was administered as a two-stage infusion during 24 hours on day 6. During one of the 8-day periods, 300 mg caffeine, t.i.d., was administered orally. After the start of the theophylline infusion, plasma concentrations of theophylline and caffeine and urinary excretion of theophylline and four metabolites were determined frequently during 60 hours. With caffeine administration theophylline steady-state concentration and area under the curve increased by 23% and 40%, respectively, whereas the volume of distribution at steady state seemed unchanged. The cumulative urinary excretion of 1-methyluric acid and 1-methylxanthine did not reach a plateau, suggesting a capacity-limiting factor in their formation. Notwithstanding the mutual interference of theophylline and caffeine metabolism, the reduction in apparent total body clearance and elimination rate constant of theophylline by 29% and 31%, respectively, indicated a pronounced influence of concomitant administration of realistic amounts of caffeine.lld:pubmed
pubmed-article:2007319pubmed:languageenglld:pubmed
pubmed-article:2007319pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2007319pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2007319pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2007319pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2007319pubmed:statusMEDLINElld:pubmed
pubmed-article:2007319pubmed:monthMarlld:pubmed
pubmed-article:2007319pubmed:issn0009-9236lld:pubmed
pubmed-article:2007319pubmed:authorpubmed-author:JonkmanJ HJHlld:pubmed
pubmed-article:2007319pubmed:authorpubmed-author:SteinijansV...lld:pubmed
pubmed-article:2007319pubmed:authorpubmed-author:SauterRRlld:pubmed
pubmed-article:2007319pubmed:authorpubmed-author:SolovyJ SJSlld:pubmed
pubmed-article:2007319pubmed:issnTypePrintlld:pubmed
pubmed-article:2007319pubmed:volume49lld:pubmed
pubmed-article:2007319pubmed:ownerNLMlld:pubmed
pubmed-article:2007319pubmed:authorsCompleteYlld:pubmed
pubmed-article:2007319pubmed:pagination248-55lld:pubmed
pubmed-article:2007319pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:meshHeadingpubmed-meshheading:2007319-...lld:pubmed
pubmed-article:2007319pubmed:year1991lld:pubmed
pubmed-article:2007319pubmed:articleTitleThe influence of caffeine on the steady-state pharmacokinetics of theophylline.lld:pubmed
pubmed-article:2007319pubmed:affiliationPharma Bio-Research International B.V., Assen., The Netherlands.lld:pubmed
pubmed-article:2007319pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2007319pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2007319pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2007319pubmed:publicationTypeControlled Clinical Triallld:pubmed